Efficacy and safety of first-line chemoimmunotherapy in young patients with extensive-stage small cell lung cancer: a multicenter retrospective study

Efficacy and safety of first-line chemoimmunotherapy in young patients with extensive-stage small cell lung cancer: a multicenter retrospective study

Abstract Objectives Chemoimmunotherapy is the first-line treatment for extensive-stage small cell lung cancer (ES-SCLC). This study aims to evaluate the survival outcomes and safety of chemoimmunotherapy in young patients with ES-SCLC. Patients and methods Patients with pathologically or cytological...

Full description

Saved in:
Bibliographic Details
Main Authors: Lijuan Zhao, Qi Xiong, Yaping Long, Haiming Hu, Zhouhuan Dong, Fengwei Zhu, Jun Zhao, Bo Yang, Jingzhi Guan
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cancer
Subjects:
Extensive-stage small cell lung cancer
Adults
Older adults
Chemoimmunotherapy
Drug-Related side effects and adverse reactions
Online Access:https://doi.org/10.1186/s12885-025-14524-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14524-y

Similar Items